MicroRNA-21 and its impact on signaling pathways in cervical cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Cervical cancer is a significant health concern for women, characterized by uncontrolled cell growth and spread.
• Oncogenic microRNA-21 (miR-21) is frequently overexpressed in cervical cancer tissues and cells.
• miR-21 plays a critical role in regulating gene expression by targeting mRNAs and long non-coding RNAs (lncRNAs).

Purpose of the Study:

• To review the evidence linking miR-21 to cervical cancer progression.
• To elucidate the molecular mechanisms by which miR-21 influences cancer cell proliferation and apoptosis.
• To assess the potential of miR-21 as a therapeutic target for cervical cancer.

Main Methods:

• Literature review of existing studies on miR-21 in cervical cancer.
• Analysis of miR-21's interactions with target mRNAs and lncRNAs.
• Examination of miR-21's role in tumor necrosis factor alpha (TNF-α) signaling pathways.

Main Results:

• miR-21 differentially regulates TNF receptor signaling, inhibiting TNFR1 and activating TNFR2 pathways.
• miR-21 promotes cervical cancer cell proliferation via the protein kinase B/mammalian target of rapamycin (Akt/mTOR) and RAS signaling pathways.
• miR-21 contributes to cervical cancer development by suppressing apoptosis and enhancing proliferation.

Conclusions:

• miR-21 is a key oncogenic factor in cervical cancer, impacting cell survival and proliferation.
• Targeting miR-21 presents a promising strategy for novel cervical cancer therapies.
• Further research into miR-21's molecular functions may lead to improved clinical interventions.